VRM
MYOV

Vectors Research Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Vectors Research Management’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-250
Closed -$3K – 519
2022
Q2 		$3K Hold
250
– – ﹤0.01% 459
2022
Q1 		$3K Hold
250
– – ﹤0.01% 429
2021
Q4 		$4K Hold
250
– – ﹤0.01% 533
2021
Q3 		$6K Hold
250
– – ﹤0.01% 411
2021
Q2 		$6K Hold
250
– – ﹤0.01% 436
2021
Q1 		$5K Hold
250
– – ﹤0.01% 392
2020
Q4 		$7K Hold
250
– – ﹤0.01% 357
2020
Q3 		$4K Hold
250
– – ﹤0.01% 363
2020
Q2 		$5K Buy
+250
New +$3.4K ﹤0.01% 352

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vectors Research Management's MYOV Position: Q3 2022 in Review

Vectors Research Management sold out of Myovant Sciences Ltd. (MYOV) in Q3 2022, closing a stake of 250 shares — an estimated $3K sold.

Vectors Research Management first reported a position in MYOV in Q2 2020 and held it in 9 quarters. The position peaked at $7K in Q4 2020. 98 funds tracked by Wall St. Rank hold MYOV as of Q3 2022.

  • Vectors Research Management reported no remaining Myovant Sciences Ltd. position as of Q3 2022 after selling out during the quarter.
  • Vectors Research Management sold 250 Myovant Sciences Ltd. shares in Q3 2022, an estimated $3K.
  • Vectors Research Management first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 9 quarters.
  • Vectors Research Management's Myovant Sciences Ltd. position peaked at $7K in Q4 2020.
  • 98 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2022.

Based on Vectors Research Management's 13F filing for Q3 2022, filed 8 Nov 2022.